Session 3: Emerging Therapies in Mesothelioma - Video 2 of 3 - Mutti
Click here to see the full list of the 2008 Symposium presentations.
|Session 3: Emerging Therapies in Mesothelioma - Video 2 of 3 - Mutti|
Since 1999 Dr. Luciano Mutti M.D, Ph.D has been the Chief of the Dept of Medicine and Head of the Lab of Clinical Oncology of Vercelli General Hospital in Italy. He is the Chair of the Scientific Committee of the Buzzi Foundation for research on Mesothelioma and of the Italian Group for the Research and therapy of Mesothelioma (GIMe), Italian Director of the International Mesothelioma Interest Group (IMIG) and expert leader of the European Respiratory Society (ERS) for Chemotherapy and novel therapies for Mesothelioma
Dr. Mutti began his research investigating the immune response against mesothelioma cells and over the last years has been coordinating a multidisciplinary team-oriented approach to mesothelioma ranging from molecular epidemiology to cell signaling transduction and novel translational therapies for this tumor. (Imatinib Mesylate, Bortezomib, Antiangiogenics and anti-CTLA4).
||Click here to view Dr. Mutti's slide presentation (pdf format)
||Click here to download the audio file of Dr. Mutti's presentation.
Click below to play video
© 2008 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)